Clarus Wealth Advisors Alkermes Plc. Transaction History

Clarus Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$19.51 - $24.28 $111,207 - $138,396	-5,700 Closed	0 $0
Q4 2018 Jan 08, 2019	BUY	$27.94 - $44.61 $159,258 - $254,277	5,700 New	5,700 $242,000
Q4 2018 Jan 07, 2019	SELL	$27.94 - $44.61 $159,258 - $254,277	-5,700 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$38.6 - $46.12 $69,480 - $83,016	1,800 Added 46.15%	5,700 $242,000
Q1 2018 May 11, 2018	SELL	$53.61 - $67.26 $42,888 - $53,808	-800 Reduced 17.02%	3,900 $226,000
Q4 2017 Feb 05, 2018	BUY	$47.69 - $55.39 $224,143 - $260,333	4,700	4,700 $257,000

346

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.76B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.